Global Biliary Atresia Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 85 pages | ID: G8AA2F321B2EN
LP Information

Abstracts

According to this study, the global Biliary Atresia Treatment market size will reach US$ million by 2031.

Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Biliary Atresia Treatment Industry Forecast” looks at past sales and reviews total world Biliary Atresia Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Biliary Atresia Treatment sales for 2025 through 2031. With Biliary Atresia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biliary Atresia Treatment industry.

This Insight Report provides a comprehensive analysis of the global Biliary Atresia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biliary Atresia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biliary Atresia Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biliary Atresia Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biliary Atresia Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Biliary Atresia Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Drug Treatment
• Surgery Treatment

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Daiichi Sankyo
• Eisai
• Johnson & Johnson
• Novartis
• Pfizer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biliary Atresia Treatment Market Size (2020-2031)
  2.1.2 Biliary Atresia Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Biliary Atresia Treatment by Country/Region (2020, 2024 & 2031)
2.2 Biliary Atresia Treatment Segment by Type
  2.2.1 Drug Treatment
  2.2.2 Surgery Treatment
2.3 Biliary Atresia Treatment Market Size by Type
  2.3.1 Biliary Atresia Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Biliary Atresia Treatment Market Size Market Share by Type (2020-2025)
2.4 Biliary Atresia Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Biliary Atresia Treatment Market Size by Application
  2.5.1 Biliary Atresia Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Biliary Atresia Treatment Market Size Market Share by Application (2020-2025)

3 BILIARY ATRESIA TREATMENT MARKET SIZE BY PLAYER

3.1 Biliary Atresia Treatment Market Size Market Share by Player
  3.1.1 Global Biliary Atresia Treatment Revenue by Player (2020-2025)
  3.1.2 Global Biliary Atresia Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Biliary Atresia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BILIARY ATRESIA TREATMENT BY REGION

4.1 Biliary Atresia Treatment Market Size by Region (2020-2025)
4.2 Global Biliary Atresia Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biliary Atresia Treatment Market Size Growth (2020-2025)
4.4 APAC Biliary Atresia Treatment Market Size Growth (2020-2025)
4.5 Europe Biliary Atresia Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Biliary Atresia Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Biliary Atresia Treatment Market Size by Country (2020-2025)
5.2 Americas Biliary Atresia Treatment Market Size by Type (2020-2025)
5.3 Americas Biliary Atresia Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biliary Atresia Treatment Market Size by Region (2020-2025)
6.2 APAC Biliary Atresia Treatment Market Size by Type (2020-2025)
6.3 APAC Biliary Atresia Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Biliary Atresia Treatment Market Size by Country (2020-2025)
7.2 Europe Biliary Atresia Treatment Market Size by Type (2020-2025)
7.3 Europe Biliary Atresia Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biliary Atresia Treatment by Region (2020-2025)
8.2 Middle East & Africa Biliary Atresia Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Biliary Atresia Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BILIARY ATRESIA TREATMENT MARKET FORECAST

10.1 Global Biliary Atresia Treatment Forecast by Region (2026-2031)
  10.1.1 Global Biliary Atresia Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Biliary Atresia Treatment Forecast
  10.1.3 APAC Biliary Atresia Treatment Forecast
  10.1.4 Europe Biliary Atresia Treatment Forecast
  10.1.5 Middle East & Africa Biliary Atresia Treatment Forecast
10.2 Americas Biliary Atresia Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Biliary Atresia Treatment Forecast
  10.2.2 Canada Market Biliary Atresia Treatment Forecast
  10.2.3 Mexico Market Biliary Atresia Treatment Forecast
  10.2.4 Brazil Market Biliary Atresia Treatment Forecast
10.3 APAC Biliary Atresia Treatment Forecast by Region (2026-2031)
  10.3.1 China Biliary Atresia Treatment Market Forecast
  10.3.2 Japan Market Biliary Atresia Treatment Forecast
  10.3.3 Korea Market Biliary Atresia Treatment Forecast
  10.3.4 Southeast Asia Market Biliary Atresia Treatment Forecast
  10.3.5 India Market Biliary Atresia Treatment Forecast
  10.3.6 Australia Market Biliary Atresia Treatment Forecast
10.4 Europe Biliary Atresia Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Biliary Atresia Treatment Forecast
  10.4.2 France Market Biliary Atresia Treatment Forecast
  10.4.3 UK Market Biliary Atresia Treatment Forecast
  10.4.4 Italy Market Biliary Atresia Treatment Forecast
  10.4.5 Russia Market Biliary Atresia Treatment Forecast
10.5 Middle East & Africa Biliary Atresia Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Biliary Atresia Treatment Forecast
  10.5.2 South Africa Market Biliary Atresia Treatment Forecast
  10.5.3 Israel Market Biliary Atresia Treatment Forecast
  10.5.4 Turkey Market Biliary Atresia Treatment Forecast
10.6 Global Biliary Atresia Treatment Forecast by Type (2026-2031)
10.7 Global Biliary Atresia Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Biliary Atresia Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Biliary Atresia Treatment Product Offered
  11.1.3 AstraZeneca Biliary Atresia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 Daiichi Sankyo
  11.2.1 Daiichi Sankyo Company Information
  11.2.2 Daiichi Sankyo Biliary Atresia Treatment Product Offered
  11.2.3 Daiichi Sankyo Biliary Atresia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Daiichi Sankyo Main Business Overview
  11.2.5 Daiichi Sankyo Latest Developments
11.3 Eisai
  11.3.1 Eisai Company Information
  11.3.2 Eisai Biliary Atresia Treatment Product Offered
  11.3.3 Eisai Biliary Atresia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Eisai Main Business Overview
  11.3.5 Eisai Latest Developments
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Information
  11.4.2 Johnson & Johnson Biliary Atresia Treatment Product Offered
  11.4.3 Johnson & Johnson Biliary Atresia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Johnson & Johnson Main Business Overview
  11.4.5 Johnson & Johnson Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis Biliary Atresia Treatment Product Offered
  11.5.3 Novartis Biliary Atresia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Biliary Atresia Treatment Product Offered
  11.6.3 Pfizer Biliary Atresia Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biliary Atresia Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biliary Atresia Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Drug Treatment
Table 4. Major Players of Surgery Treatment
Table 5. Biliary Atresia Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Biliary Atresia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Biliary Atresia Treatment Market Size Market Share by Type (2020-2025)
Table 8. Biliary Atresia Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Biliary Atresia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Biliary Atresia Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Biliary Atresia Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Biliary Atresia Treatment Revenue Market Share by Player (2020-2025)
Table 13. Biliary Atresia Treatment Key Players Head office and Products Offered
Table 14. Biliary Atresia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biliary Atresia Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Biliary Atresia Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Biliary Atresia Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Biliary Atresia Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Biliary Atresia Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Biliary Atresia Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Biliary Atresia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Biliary Atresia Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Biliary Atresia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Biliary Atresia Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Biliary Atresia Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Biliary Atresia Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Biliary Atresia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Biliary Atresia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Biliary Atresia Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Biliary Atresia Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Biliary Atresia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Biliary Atresia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Biliary Atresia Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Biliary Atresia Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Biliary Atresia Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Biliary Atresia Treatment
Table 39. Key Market Challenges & Risks of Biliary Atresia Treatment
Table 40. Key Industry Trends of Biliary Atresia Treatment
Table 41. Global Biliary Atresia Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Biliary Atresia Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Biliary Atresia Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Biliary Atresia Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AstraZeneca Details, Company Type, Biliary Atresia Treatment Area Served and Its Competitors
Table 46. AstraZeneca Biliary Atresia Treatment Product Offered
Table 47. AstraZeneca Biliary Atresia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZeneca Main Business
Table 49. AstraZeneca Latest Developments
Table 50. Daiichi Sankyo Details, Company Type, Biliary Atresia Treatment Area Served and Its Competitors
Table 51. Daiichi Sankyo Biliary Atresia Treatment Product Offered
Table 52. Daiichi Sankyo Biliary Atresia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Daiichi Sankyo Main Business
Table 54. Daiichi Sankyo Latest Developments
Table 55. Eisai Details, Company Type, Biliary Atresia Treatment Area Served and Its Competitors
Table 56. Eisai Biliary Atresia Treatment Product Offered
Table 57. Eisai Biliary Atresia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Eisai Main Business
Table 59. Eisai Latest Developments
Table 60. Johnson & Johnson Details, Company Type, Biliary Atresia Treatment Area Served and Its Competitors
Table 61. Johnson & Johnson Biliary Atresia Treatment Product Offered
Table 62. Johnson & Johnson Biliary Atresia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Latest Developments
Table 65. Novartis Details, Company Type, Biliary Atresia Treatment Area Served and Its Competitors
Table 66. Novartis Biliary Atresia Treatment Product Offered
Table 67. Novartis Biliary Atresia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 70. Pfizer Details, Company Type, Biliary Atresia Treatment Area Served and Its Competitors
Table 71. Pfizer Biliary Atresia Treatment Product Offered
Table 72. Pfizer Biliary Atresia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Biliary Atresia Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biliary Atresia Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biliary Atresia Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biliary Atresia Treatment Sales Market Share by Country/Region (2024)
Figure 8. Biliary Atresia Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biliary Atresia Treatment Market Size Market Share by Type in 2024
Figure 10. Biliary Atresia Treatment in Hospital
Figure 11. Global Biliary Atresia Treatment Market: Hospital (2020-2025) & ($ millions)
Figure 12. Biliary Atresia Treatment in Clinic
Figure 13. Global Biliary Atresia Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Biliary Atresia Treatment in Others
Figure 15. Global Biliary Atresia Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Biliary Atresia Treatment Market Size Market Share by Application in 2024
Figure 17. Global Biliary Atresia Treatment Revenue Market Share by Player in 2024
Figure 18. Global Biliary Atresia Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Biliary Atresia Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Biliary Atresia Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Biliary Atresia Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Biliary Atresia Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Biliary Atresia Treatment Value Market Share by Country in 2024
Figure 24. United States Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Biliary Atresia Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Biliary Atresia Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Biliary Atresia Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Biliary Atresia Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Biliary Atresia Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Biliary Atresia Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Biliary Atresia Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Biliary Atresia Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Biliary Atresia Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Biliary Atresia Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Biliary Atresia Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Biliary Atresia Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Biliary Atresia Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Biliary Atresia Treatment Market Size 2026-2031 ($ millions)